Trade Getinge B - GETIb CFD

Trading Conditions

• TypeThis financial instrument is available for trading through CFDs and Knock-outs.Knock-out options available only for selected countries.Learn more about:CFDsKnock-outs:
  CFD

  

  Knock-out

  
• Spread: 0.9
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investmentSEK 1,000.00Overnight funding adjustmentCharges from full value of position-0.015669 %(-SEK 0.80)Trade size with leverage ~ SEK 5,000.00Money from leverage ~SEK 4,000.00Go to platform: -0.01567%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investmentSEK 1,000.00Overnight funding adjustmentCharges from full value of position-0.006554 %(-SEK 0.30)Trade size with leverage ~ SEK 5,000.00Money from leverage ~SEK 4,000.00Go to platform: -0.00655%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: SEK
• Min traded quantity: 1
• Margin: 20.00%
• Stock exchange: Sweden
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: SEK 1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.015669 %
  (-SEK 0.80)

• Margin. Your investment: SEK 1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.006554 %
  (-SEK 0.30)

Key Stats

• Prev. Close: 206.1
• Open: 205.4
• 1-Year Change: 9.55%
• Day's Range: 205.4 - 209.8

Trade Getinge B - GETIb

About Getinge AB

Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, GetingeAB revenues decreased 9% to SEK27.05B. Net incomeapplicable to common stockholders decreased 8% to SEK2.97B.Revenues reflect a decrease in demand for the Company'sproducts and services due to unfavorable market conditions.Net income also reflects Research & Development Expenditure, Cap decrease of 19% to SEK346M (income), Acquisitionexpenses increase from SEK8M to SEK35M (expense).

Equity composition

April 2001: Bonus Issue, adjustment factor 0.9717.November 2003: Stock Split in the ratio 1:4. 02/2008,Rights Issue, 1 new share for every 16 shares held @ SEK120 (Factor: 1.014783). 11/2008, Rights Issue, 1 new sharefor every 9 shares held @ SEK 83.5 (Factor: 1.01930).